(Q53670629)

17 May 2018

title

Clinical effects of long-term administration of pimobendan in patients with moderate congestive heart failure. (English)

1 reference

17 May 2018

main subject

congestive heart failure

1 reference

S Sasayama

1

1 reference

17 May 2018

H Asanoi

2

1 reference

17 May 2018

Y Kihara

3

1 reference

17 May 2018

S Yokawa

4

1 reference

17 May 2018

Y Terada

5

1 reference

17 May 2018

S Yoshida

6

1 reference

17 May 2018

M Ejiri

7

1 reference

17 May 2018

I Horikoshi

8

1 reference

17 May 2018

publication date

1 January 1994

1 reference

17 May 2018

published in

Heart and Vessels

1 reference

17 May 2018

volume

9

1 reference

17 May 2018

issue

3

1 reference

17 May 2018

page(s)

113-120

1 reference

17 May 2018

https://scigraph.springernature.com/pub.10.1007/bf01745236

exact match

0 references

cites work

Current therapy of the failing heart

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF01745236

Pimobendane (UD-CG 115 BS) in the treatment of severe congestive heart failure. An acute haemodynamic cross-over and double-blind study with two different doses

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF01745236

A placebo-controlled, randomized, double-blind study of OPC-8212 in patients with mild chronic heart failure. OPC-8212 Multicenter Research Group

21 January 2018

1 reference

12 December 2020

Post-extrasystolic potentiation and the force-frequency relationship: Differential augmentation of myocardial contractility in working myocardium from patients with end-stage heart failure

1 reference

12 December 2020

Phosphodiesterase-inhibiting properties of newer inotropic agents

1 reference

12 December 2020

Sensitization of dog and guinea pig heart myofilaments to Ca2+ activation and the inotropic effect of pimobendan: comparison with milrinone

1 reference

12 December 2020

Influence of the positive inotropic substance pimobendan (UD-CG 115 BS) on contractile economy of guinea pig papillary muscles.

1 reference

12 December 2020

Effects of vesnarinone on morbidity and mortality in patients with heart failure. Vesnarinone Study Group

1 reference

12 December 2020

Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group

1 reference

12 December 2020

Usefulness of OPC-8212, a quinolinone derivative, for chronic congestive heart failure in patients with ischemic heart disease or idiopathic dilated cardiomyopathy

1 reference

12 December 2020

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

1 reference

12 December 2020

Cellular mechanisms in congestive heart failure

1 reference

12 December 2020

Pimobendan increases survival of cardiomyopathic hamsters

1 reference

12 December 2020

Cardiovascular profile of pimobendan, a benzimidazole-pyridazinone derivative with vasodilating and inotropic properties.

1 reference

12 December 2020

Acute and long-term hemodynamic effects of pimobendan (UD-CG 115 BS) in comparison with captopril.

1 reference

12 December 2020

Do positive inotropic agents adversely affect the survival of patients with chronic congestive heart failure? I. Introduction

1 reference

12 December 2020

Comparative reproducibility and validity of systems for assessing cardiovascular functional class: advantages of a new specific activity scale

1 reference

12 December 2020

Influence of the calcium-sensitizer UDCG-115 on hemodynamics and myocardial energetics in patients with idiopathic dilated cardiomyopathy. Comparison with nitroprusside

1 reference

12 December 2020

Cardiovascular effects and plasma level profile of pimobendan (UD-CG 115 BS) and its metabolite UD-CG 212 in patients with congestive heart failure after single and repeated oral dosing

1 reference

12 December 2020

Effects of new inotropic agents on Ca++ sensitivity of contractile proteins

1 reference

12 December 2020

Intractable heart failure despite angiotensin-converting enzyme inhibitors, digoxin, and diuretics: Long-term effectiveness of add-on therapy with pimobendan

1 reference

12 December 2020

Long-term efficacy and safety of pimobendan in moderate heart failure. A double-blind parallel 6-month comparison with enalapril. The Pimobendan-Enalapril Study Group

1 reference

12 December 2020

Pimobendane (UD-CG 115 BS) in chronic congestive heart failure. Short-term and one-month effects of a new inotropic vasodilating agent

1 reference

12 December 2020

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

12 December 2020

Effects of the benzimidazole derivatives pimobendan and 2-(4-hydroxy-phenyl)-5-(5-methyl-3-oxo-4,5-dihydro-2H-6- pyridazinyl) benzimidazole . HCl on phosphodiesterase activity and force of contraction in guinea-pig hearts.

1 reference

12 December 2020

Beneficial effects of pimobendan on exercise tolerance and quality of life in patients with heart failure. Results of a multicenter trial. The Pimobendan Multicenter Research Group

1 reference

12 December 2020

Calcium-sensitivity modulation of cardiac myofibrillar proteins

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01745236

1 reference

17 May 2018

1 reference

17 May 2018